Us Bancorp \De\ Vanda Pharmaceuticals Inc. Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 27,244 shares of VNDA stock, worth $131,588. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,244

Previous 28,387 4.03%

Holding current value

$131,588

Previous $160,000 20.63%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$4.61 - $6.34 $5,269 - $7,246	-1,143 Reduced 4.03%	27,244 $127,000
Q1 2024 May 07, 2024	SELL	$3.47 - $4.61 $8,775 - $11,658	-2,529 Reduced 8.18%	28,387 $116,000
Q4 2023 Feb 09, 2024	BUY	$3.38 - $4.58 $103,275 - $139,941	30,555 Added 8463.99%	30,916 $130,000
Q3 2023 Nov 03, 2023	SELL	$4.28 - $6.57 $11,157 - $17,127	-2,607 Reduced 87.84%	361 $1,000
Q2 2023 Aug 09, 2023	BUY	$5.9 - $6.95 $15,381 - $18,118	2,607 Added 722.16%	2,968 $19,000
Q1 2023 May 09, 2023	SELL	$6.18 - $7.99 $852 - $1,102	-138 Reduced 27.66%	361 $2,000
Q3 2022 Oct 27, 2022	SELL	$9.44 - $11.76 $9,742 - $12,136	-1,032 Reduced 67.41%	499 $5,000
Q2 2022 Aug 01, 2022	BUY	$9.31 - $11.84 $4,468 - $5,683	480 Added 45.67%	1,531 $17,000
Q1 2022 May 11, 2022	BUY	$10.84 - $16.55 $9,148 - $13,968	844 Added 407.73%	1,051 $12,000
Q3 2021 Nov 10, 2021	SELL	$15.35 - $21.27 $9,808 - $13,591	-639 Reduced 75.53%	207 $4,000
Q1 2021 Apr 28, 2021	BUY	$13.42 - $20.28 $5,368 - $8,112	400 Added 89.69%	846 $13,000
Q4 2020 Feb 04, 2021	SELL	$9.77 - $13.81 $4,670 - $6,601	-478 Reduced 51.73%	446 $6,000
Q3 2020 Nov 10, 2020	SELL	$9.32 - $12.02 $5,694 - $7,344	-611 Reduced 39.8%	924 $9,000
Q2 2020 Aug 07, 2020	SELL	$9.66 - $12.02 $4,965 - $6,178	-514 Reduced 25.09%	1,535 $17,000
Q1 2020 May 13, 2020	SELL	$7.5 - $16.8 $9,097 - $20,378	-1,213 Reduced 37.19%	2,049 $22,000
Q4 2019 Feb 04, 2020	SELL	$12.38 - $17.47 $41,646 - $58,769	-3,364 Reduced 50.77%	3,262 $53,000
Q3 2019 Nov 08, 2019	SELL	$12.27 - $15.79 $242,222 - $311,710	-19,741 Reduced 74.87%	6,626 $88,000
Q2 2019 Aug 13, 2019	SELL	$13.37 - $18.85 $182,981 - $257,981	-13,686 Reduced 34.17%	26,367 $372,000
Q1 2019 May 08, 2019	BUY	$17.59 - $31.05 $120,403 - $212,537	6,845 Added 20.61%	40,053 $737,000
Q4 2018 Feb 13, 2019	BUY	$18.97 - $31.47 $116,058 - $192,533	6,118 Added 22.58%	33,208 $868,000
Q3 2018 Nov 01, 2018	BUY	$18.25 - $23.0 $488,771 - $615,986	26,782 Added 8695.45%	27,090 $621,000
Q2 2018 Aug 08, 2018	BUY	$13.95 - $19.15 $2,064 - $2,834	148 Added 92.5%	308 $6,000
Q1 2018 May 08, 2018	SELL	$14.05 - $20.2 $43,049 - $61,892	-3,064 Reduced 95.04%	160 $3,000
Q4 2017 Feb 02, 2018	BUY	$12.85 - $18.1 $37,573 - $52,924	2,924 Added 974.67%	3,224 $49,000
Q3 2017 Nov 13, 2017	BUY	$15.4 - $18.85 $4,620 - $5,655	300	300 $5,000

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $273M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account